日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

PEAKS activation by PROTAC EPIC-0726 potentiates temozolomide in glioblastoma via K63/K48 ubiquitination-dependent ERK/AKT suppression and p21 stabilization

PROTAC EPIC-0726 通过 K63/K48 泛素化依赖的 ERK/AKT 抑制和 p21 稳定增强 PEAKS 激活,从而增强替莫唑胺在胶质母细胞瘤中的疗效。

Hong, Biao; Su, Dongyuan; Cui, Xiaoteng; Zhao, Jixing; Wang, Qixue; Zhan, Qi; Yang, Eryan; Yang, Shixue; Ju, Jiasheng; Huang, Yanping; Cheng, Chunchao; Ding, Yaqing; Xu, Hanyi; Cui, Longtao; Zhao, Yilin; Zhao, Xun; Liang, Siwen; Liu, Yuhao; Kang, Chunsheng

LPC-engineered liposomes activate transcytosis for paclitaxel brain delivery and potentiation of TTFields/TMZ via TALECT regimen in glioblastoma

LPC工程化脂质体通过TALECT方案激活胞吞作用,将紫杉醇递送至脑部,并增强TTFields/TMZ在胶质母细胞瘤中的疗效。

Zhan, Qi; Yi, Kaikai; Yang, Shixue; Hong, Biao; Su, Dongyuan; Zhao, Jixing; Wang, Qixue; Cui, Xiaoteng; Huang, Yanping; Ding, Yaqing; Cheng, Chunchao; Ju, Jiasheng; Kang, Chunsheng

Different variation of right upper lung apex subsegment

右肺上叶尖段的不同变异

Yan, Wu; Wang, MengXuan; Li, YongSheng; Zhao, JiXing

Linagliptin synergizes with cPLA2 inhibition to enhance temozolomide efficacy by interrupting DPP4-mediated EGFR stabilization in glioma.

利格列汀与 cPLA2 抑制剂协同作用,通过干扰 DPP4 介导的 EGFR 在胶质瘤中的稳定作用来增强替莫唑胺的疗效

Su Dongyuan, Hong Biao, Yang Shixue, Zhao Jixing, Cui Xiaoteng, Zhan Qi, Yi Kaikai, Huang Yanping, Ju Jiasheng, Yang Eryan, Wang Qixue, Zhou Junhu, Wang Yunfei, Liu Xing, Kang Chunsheng

HIF1α/ATF3 partake in PGK1 K191/K192 succinylation by modulating P4HA1/succinate signaling in glioblastoma

HIF1α/ATF3通过调节胶质母细胞瘤中的P4HA1/琥珀酸信号通路参与PGK1 K191/K192的琥珀酰化。

Yang, Shixue; Zhan, Qi; Su, Dongyuan; Cui, Xiaoteng; Zhao, Jixing; Wang, Qixue; Hong, Biao; Ju, Jiasheng; Cheng, Chunchao; Yang, Eryan; Kang, Chunsheng

EPIC-1042 as a potent PTRF/Cavin1-caveolin-1 interaction inhibitor to induce PARP1 autophagic degradation and suppress temozolomide efflux for glioblastoma

EPIC-1042 是一种强效的 PTRF/Cavin1-caveolin-1 相互作用抑制剂,可诱导 PARP1 自噬降解并抑制替莫唑胺外排,用于治疗胶质母细胞瘤。

Hong, Biao; Yang, Eryan; Su, Dongyuan; Ju, Jiasheng; Cui, Xiaoteng; Wang, Qixue; Tong, Fei; Zhao, Jixing; Yang, Shixue; Cheng, Chunchao; Xin, Lei; Xiao, Menglin; Yi, Kaikai; Zhan, Qi; Ding, Yaqing; Xu, Hanyi; Cui, Longtao; Kang, Chunsheng

Retraction of "Universal theranostic CRISPR/Cas13a RNA-editing system for glioma"

撤回“用于胶质瘤的通用诊疗一体化 CRISPR/Cas13a RNA 编辑系统”

Wu, Ye; Wang, Yunfei; Zhou, Junhu; Wang, Jianhao; Zhan, Qi; Wang, Qixue; Yang, Eryan; Jin, Weili; Tong, Fei; Zhao, Jixing; Hong, Biao; Liu, Junrui; Kang, Chunsheng

Different anatomical variations in the anterior segment of the right upper lung

右上肺前段的不同解剖变异

Yan, Wu; Wang, MengXuan; Zhao, JiXing; Li, YongSheng; Wei, Wei

A novel compound EPIC-0412 reverses temozolomide resistance via inhibiting DNA repair/MGMT in glioblastoma

一种新型化合物 EPIC-0412 通过抑制胶质母细胞瘤中的 DNA 修复/MGMT 来逆转替莫唑胺耐药性

Zhao, Jixing; Yang, Shixue; Cui, Xiaoteng; Wang, Qixue; Yang, Eryan; Tong, Fei; Hong, Biao; Xiao, Menglin; Xin, Lei; Xu, Can; Tan, Yanli; Kang, Chunsheng

Universal theranostic CRISPR/Cas13a RNA-editing system for glioma

用于胶质瘤的通用型诊疗一体化 CRISPR/Cas13a RNA 编辑系统

Wu, Ye; Wang, Yunfei; Zhou, Junhu; Wang, Jianhao; Zhan, Qi; Wang, Qixue; Yang, Eryan; Jin, Weili; Tong, Fei; Zhao, Jixing; Hong, Biao; Liu, Junrui; Kang, Chunsheng